STOCK TITAN

Philip Morris - PM STOCK NEWS

Welcome to our dedicated page for Philip Morris news (Ticker: PM), a resource for investors and traders seeking the latest updates and insights on Philip Morris stock.

Overview

Philip Morris International (PM) is a US-rooted, globally operating multinational specializing in manufacturing and marketing tobacco products alongside a growing portfolio of reduced-risk alternatives. With its presence in over 180 countries, PM has established itself as a key figure in the realm of Big Tobacco, recognized particularly by its flagship cigarette brand, Marlboro. The company leverages extensive experience and industry expertise to navigate rigorous regulatory environments while maintaining a diversified product range.

Business Model and Operations

At its core, PM generates revenue through the global sale of a broad spectrum of nicotine delivery products. Traditionally centered on cigarettes, its business model has expanded to include alternative offerings designed to reduce harm, such as heatsticks, vaping products, and oral nicotine solutions. This strategic diversification not only caters to varying consumer preferences worldwide but also underscores the company's proactive approach to evolving market demands and regulatory pressures. Its operational infrastructure supports a complex supply and distribution chain that spans multiple continents, ensuring robust market penetration and geographic diversity.

Product Portfolio and Diversification

The company's product portfolio is characterized by its dual focus on traditional tobacco products and emerging reduced-risk alternatives. This includes:

  • Cigarettes: Long-established and performance-tested products that have solidified the company's reputation globally.
  • Reduced-Risk Alternatives: Heatsticks, sophisticated vaping devices, and a range of oral nicotine offerings that aim to provide consumers with less harmful options.

An important turning point in PM's strategic evolution was the integration of new product categories, which enabled its entry into markets traditionally dominated by oral tobacco products. This move, achieved through strategic acquisitions, reflects the company's commitment to innovation and responsiveness to shifting consumer habits while retaining its commitment to quality and compliance.

Global Market Presence and Competitive Landscape

Philip Morris International operates within a highly competitive and regulated industry. Its global footprint, extensive distribution channels, and brand equity distinguish it from its competitors. The company faces challenges from both established tobacco conglomerates and emerging players in the reduced-risk segment. However, its longstanding market presence and continuous product innovation ensure that it remains a critical participant in discussions involving consumer behavior and industry regulatory trends.

Industry Dynamics and Regulatory Navigation

Operating in a sector marked by stringent regulatory oversight, PM demonstrates rigorous adherence to compliance policies and safety standards. Its business strategy carefully balances consumer demand with proactive risk management, ensuring that its products meet high standards of quality and safety. This focus on regulatory compliance alongside continuous innovation enables PM to sustain long-term operational stability despite evolving legal and market environments.

Expertise and Value Proposition

Philip Morris International offers a comprehensive value proposition by blending a legacy of established tobacco products with forward-thinking initiatives in reduced-risk nicotine delivery. The company's strategic expansion beyond conventional cigarettes into innovative product categories illustrates its commitment to addressing diverse consumer needs while simultaneously fortifying its market position. Its industry-specific expertise, underscored by detailed product and process knowledge, enables PM to maintain relevance in a dynamic and competitive global market.

Conclusion

In summary, Philip Morris International stands as a multifaceted entity within the global tobacco industry. It embraces both traditional and modern approaches to nicotine consumption, successfully integrating a diversified product portfolio with a well-organized global operational framework. This blend of heritage and innovation not only secures its prominence in international markets but also provides a clear example of how companies in regulated sectors can evolve while staying true to their core business values.

Rhea-AI Summary

The FDA has renewed the modified risk tobacco product (MRTP) authorization for eight General snus products from Swedish Match, a Philip Morris International (PM) affiliate. This renewal allows Swedish Match to market these products as lower-risk alternatives to cigarettes. The authorization was based on 330 scientific studies, including epidemiological research from Sweden, which has one of the world's lowest smoking rates. The products can be marketed with claims that using General snus instead of cigarettes reduces the risk of various tobacco-related diseases. This marks a significant milestone as PMI affiliates have now secured 13 of the 16 MRTP authorizations granted by the FDA.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.58%
Tags
-
Rhea-AI Summary

Philip Morris International (PMI) reported strong Q3 2024 results, raising its full-year guidance. Key highlights include:

- Reported Diluted EPS grew 49.2% to $1.97
- Adjusted Diluted EPS increased 14.4% to $1.91
- Smoke-free business accounted for 38% of total net revenues and 40% of gross profit
- IQOS HTU adjusted in-market sales volume up 14.8%
- ZYN nicotine pouch shipments in the U.S. grew 41.4% to 149.1 million cans
- Combustibles net revenues grew 5.2% (8.6% organically)

PMI raised its 2024 full-year guidance for reported diluted EPS to $6.20-$6.26 and adjusted diluted EPS to $6.45-$6.51. The company expects 14-15% growth in adjusted diluted EPS excluding currency impacts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.47%
Tags
-
Rhea-AI Summary

Philip Morris International (PMI) has been informed of a proposed plan to resolve tobacco product-related claims and litigation in Canada. The plan, filed by a court-appointed mediator, involves PMI's deconsolidated Canadian affiliate, Rothmans, Benson & Hedges Inc. (RBH), along with two other tobacco companies. Under the proposal, the companies would pay an aggregate settlement of CAD 32.5 billion (approximately USD 23.5 billion).

The settlement would be funded through upfront payments and annual contributions based on the companies' net income. If approved and implemented, the plan would release claims against RBH and its affiliates, including PMI, related to tobacco products. PMI CEO Jacek Olczak welcomed this step towards resolving long-pending litigation in Canada.

If RBH is reconsolidated, it is expected to be incremental to PMI's key financial metrics. The plan remains subject to further negotiation, court orders, voting by claimants, and court approval. Voting is proposed for December 2024, with a potential approval hearing in the first half of 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.06%
Tags
none
Rhea-AI Summary

Philip Morris International (PMI) (NYSE: PM) will host a live audio webcast on October 22, 2024, at 9:00 a.m. ET to discuss its 2024 third-quarter and first nine-months results. The results will be issued at approximately 7:00 a.m. ET the same day. The webcast, hosted by CFO Emmanuel Babeau, will be available at www.pmi.com/2024Q3earnings and through PMI's Investor Relations App.

PMI is a leading tobacco company transitioning towards a smoke-free future. As of June 30, 2024, PMI's smoke-free products were available in 90 markets, with an estimated 36.5 million adult users. Smoke-free business accounted for approximately 38% of PMI's total first-half 2024 net revenues. The company is also expanding into wellness and healthcare areas through its Vectura Fertin Pharma business.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.28%
Tags
conferences earnings
-
Rhea-AI Summary

Molex, parent company of Phillips Medisize, has announced an agreement to acquire Vectura Group from Philip Morris International (NYSE: PM). This acquisition aims to expand Phillips Medisize's drug delivery capabilities in inhalation. Vectura, based in Chippenham, UK, is a leader in inhalation drug device design and formulation.

The combination of Phillips Medisize and Vectura will enhance their ability to deliver a broader portfolio of inhalation combination drug devices and solutions to pharmaceutical customers. Vectura brings expertise in formulation and device development for various inhalation products, including dry powder inhalers, pressurized metered dose inhalers, and nasal and nebulizer products.

The acquisition is expected to close by the end of 2024, subject to regulatory approvals and other customary closing conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.18%
Tags
-
Rhea-AI Summary

Philip Morris International's (PMI) subsidiary, Vectura Fertin Pharma, has announced the sale of Vectura Group to Molex Asia Holdings for GBP 150 million upfront, with potential deferred payments of up to GBP 148 million. The deal includes master service agreements for developing inhaled therapeutics. Vectura will be operated by Phillips Medisize, a Molex company.

PMI CEO Jacek Olczak stated that while Vectura has been important in developing their inhaled therapeutics pipeline, opposition to PMI's transformation has impacted Vectura's scientific engagement and commercial relationships. The remaining Vectura Fertin Pharma units will continue under PMI, focusing on oral consumer health and inhaled prescription products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.18%
Tags
none
Rhea-AI Summary

Philip Morris International (NYSE: PM) has announced a 3.8% increase in its regular quarterly dividend to an annualized rate of $5.40 per share. The new quarterly dividend of $1.35 per share will be payable on October 10, 2024, to shareholders of record as of September 26, 2024. This move demonstrates PMI's commitment to delivering value to shareholders while pursuing its smoke-free future strategy.

PMI's current portfolio includes cigarettes and smoke-free products, with the company investing over $12.5 billion since 2008 to develop and commercialize innovative smoke-free alternatives. As of June 30, 2024, PMI's smoke-free products were available in 90 markets, with an estimated 36.5 million adult users globally. The smoke-free business accounted for approximately 38% of PMI's total first-half 2024 net revenues.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.49%
Tags
dividends
-
Rhea-AI Summary

Philip Morris International (PMI) warns about high levels of illicit cigarette consumption in the European Union, with 35.2 billion illicit cigarettes consumed in 2023, accounting for 8.3% of total consumption. The KPMG report commissioned by PMI reveals that counterfeit cigarettes remain a major source of illicit consumption, with 12.7 billion cigarettes consumed. France leads as the country with the largest illicit consumption in Europe, with 16.8 billion illicit cigarettes and an estimated €7.3 billion in lost tax revenues.

PMI calls for a holistic approach to curb illicit trade, including law enforcement, awareness campaigns, and a predictable fiscal environment. The company emphasizes the need for innovative approaches to reduce smoking prevalence and advocates for smoke-free alternatives. PMI's survey across 14 European countries shows that 60% of adults believe their country has a problem with illicit tobacco products, and 77% agree that illicit trade robs governments of significant tax revenue.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.3%
Tags
none
-
Rhea-AI Summary

Philip Morris International (PMI) reaffirms its 2024 full-year forecast at the Barclays Global Consumer Staples Conference. CEO Jacek Olczak will participate in a fireside chat, which will be webcast live. PMI maintains its projected reported diluted EPS of $5.89 to $6.01 and adjusted diluted EPS of $6.33 to $6.45, representing a currency-neutral growth of 11% to 13% compared to 2023. The forecast accounts for a total 2024 adjustment of $0.44 per share and an unfavorable currency impact of $0.34 per share. This projection is based on the same assumptions communicated in PMI's July 23, 2024 earnings release.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.96%
Tags
none
Rhea-AI Summary

Philip Morris International (PMI) will host a live webcast of a fireside chat session with CEO Jacek Olczak at the 2024 Barclays Global Consumer Staples Conference on September 3, 2024, at 12:45 p.m. ET. The webcast will be available at www.pmi.com/2024barclays and through PMI's Investor Relations Mobile App.

PMI, a leading tobacco company, is actively pursuing a smoke-free future. Since 2008, the company has invested over $12.5 billion in developing and commercializing innovative smoke-free products. In 2022, PMI acquired Swedish Match, creating a global smoke-free champion led by IQOS and ZYN brands. As of June 30, 2024, PMI's smoke-free products were available in 90 markets, with an estimated 36.5 million adult users worldwide. Smoke-free business accounted for approximately 38% of PMI's total first-half 2024 net revenues.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.96%
Tags
conferences

FAQ

What is the current stock price of Philip Morris (PM)?

The current stock price of Philip Morris (PM) is $156.17 as of April 2, 2025.

What is the market cap of Philip Morris (PM)?

The market cap of Philip Morris (PM) is approximately 245.5B.

What is Philip Morris International's primary business?

Philip Morris International primarily focuses on manufacturing and selling tobacco products along with a diversified portfolio of reduced-risk nicotine alternatives.

What products does PM offer beyond traditional cigarettes?

Beyond traditional cigarettes, PM offers reduced-risk products such as heatsticks, vaping devices, and various oral nicotine solutions.

How does the company diversify its product portfolio?

The company strategically broadens its range by integrating alternative nicotine delivery systems and acquiring businesses that specialize in oral tobacco products, thus expanding its market reach.

What distinguishes Philip Morris International in the competitive landscape?

Its robust global presence, an iconic brand history with products like Marlboro, and a disciplined approach to product innovation and regulatory compliance set it apart from competitors.

In which regions does PM operate?

Philip Morris International operates in over 180 countries, with a strong focus on international markets, particularly outside its home country.

How does PM manage regulatory challenges?

The company adheres to strict compliance measures and continuously evolves its product safety standards to meet the rigorous regulatory demands present in the tobacco and nicotine industries.

What are the key revenue streams for the company?

Its revenue streams are primarily driven by sales of traditional tobacco products and an increasingly significant share from reduced-risk product categories.

How does PM compare with other tobacco giants?

Philip Morris International is noted for combining a long-standing legacy in traditional cigarettes with sustainable efforts in reduced-risk innovations, thereby maintaining a unique market position among its global peers.
Philip Morris

NYSE:PM

PM Rankings

PM Stock Data

245.46B
1.55B
0.15%
81.05%
1.1%
Tobacco
Cigarettes
Link
United States
STAMFORD